ONCAlert | Upfront Therapy for mRCC
Targeted Therapies introduces Investigator Perspectives, a video editorial series featuring thought leaders who provide expert perspectives on the latest advances in cancer care.
Select a Topic: – Select a topic –
Kidney Cancer
General Cancer
Breast Cancer
Ovarian Cancer
Prostate Cancer
Lung Cancer
Multiple Myeloma
Browse by Series: – Select a Series –
Upfront Therapy for mRCC
NKTR-214 & Nivolumab: Synergistic Activity Across Tumor Types
Endocrine Therapy for HR+ Metastatic Breast Cancer
PARP Inhibitors in Ovarian Cancer
Changing Treatment Landscape in Nonmetastatic CRPC
Immunotherapy in Unresectable Locally Advanced NSCLC
Treatment of Newly Diagnosed Advanced Kidney Cancer
Immunotherapy Use in Newly Diagnosed NSCLC
IMiD Sequencing in Multiple Myeloma
